23 May 2013
Keywords: mylan, prices, public, offerings, drugmaker, priced, concurrent
Article | 19 November 2007
US drugmaker Mylan has priced concurrent public offerings pursuant to a shelf registration statement previously filed with the Securities and
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 November 2007
© 2013 thepharmaletter.com